DNA-Binding Proteins

Effects of mutant TDP-43 on the Nrf2/ARE pathway and protein expression of MafK and JDP2 in NSC-34 cells.

Y. P. Tian, Che, F. Y., Su, Q. P., Lu, Y. C., You, C. P., Huang, L. M., Wang, S. G., Wang, L., and Yu, J. X., “Effects of mutant TDP-43 on the Nrf2/ARE pathway and protein expression of MafK and JDP2 in NSC-34 cells.”, Genet Mol Res, vol. 16, no. 2, 2017.

Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.

Y. Shen, Ye, Y. F., Ruan, L. W., Bao, L., Wu, M. W., and Zhou, Y., “Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.”, Genet Mol Res, vol. 16, no. 1, 2017.

CASE-REPORT Dysregulation of gene expression in a patient with depressive disorder after transient ischemic attack confirmed by a neurophysiological neuromarker.

M. Trystuła, Żychowska, M., Wilk-Frańczuk, M., Kropotov, J. D., and Pąchalska, M., “CASE-REPORT Dysregulation of gene expression in a patient with depressive disorder after transient ischemic attack confirmed by a neurophysiological neuromarker.”, Genet Mol Res, vol. 16, no. 1, 2017.

Role of XRCC1 gene polymorphisms in non-small cell lung cancer cisplatin-based chemotherapy, and their effect on clinical and pathological characteristics.

H. F. Liu, Liu, J. S., Deng, J. H., and Wu, R. R., “Role of XRCC1 gene polymorphisms in non-small cell lung cancer cisplatin-based chemotherapy, and their effect on clinical and pathological characteristics.”, Genet Mol Res, vol. 15, no. 4, 2016.